Media Coverage

Computers and Newspapers

Media Coverage

Targeting a Key Marker of Clotting and Inflammation in COVID-19 Patients

CalciMedica’s Auxora reduces D-Dimer levels in Covid-19 trial

Targeting Calcium Overload Could Improve Stroke Outcomes

A Journey: Biotech, FDA, and Safety Committee Responses to COVID

Dr. Hebbar of CalciMedica Talks Auxora Clinical Trial Targeting COVID-19, CRAC, and More| Podcast S2 E36

Companies To Watch: CalciMedica

Dozens of Houston’s sickest COVID-19 patients picked for trial of new drug that could reduce need for ventilator by 50 percent

FDA greenlights expansion of COVID-19 study to VCU Medical Center after positive data

VC Daily: Biotech Startups Ramp Up Funding and Fight Against Coronavirus; Companies Face New Privacy Ruling

CalciMedica’s Auxora Shows Promise As COVID-19 Treatment, Patients Recovered Twice As Fast

San Diego biotech’s drug shows early promise in treating COVID-19 pneumonia

A drug for COVID-19 breathing problems, tested in Minnesota, shows promise

Interim analysis indicates Auxora™ is effective in severe COVID-19 pneumonia patients

Leadership During COVID-19 — A Biopharma CEO Roundtable

Biopharmas work to wallop COVID-19 respiratory effects, keeping patients off ventilators

Experimental Drugs May Help Keep COVID-19 Patients Off Ventilators

San Diego biotech company launches trials of drug to treat COVID-19 pneumonia

Designed for something else, SD company tests drug on COVID-19 patients

Regions Hospital to test pancreatitis drug for coronavirus effectiveness

Coronavirus In Minnesota: HealthPartners Begins Clinical Trial For Drug To Treat COVID-19 Pneumonia Patients

St. Paul hospital to test pancreatitis drug for coronavirus effectiveness


FDA permits study of local company drug to prevent COVID-19 patients from needing ventilators

CalciMedica moves inflammation-targeting COVID-19 drug into phase 2

Scroll to Top